QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL01 ANTINEOPLASTIC AGENTS
QL01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
QL01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
QL01FF01 nivolumab
QL01FF02 pembrolizumab
QL01FF03 durvalumab
QL01FF04 avelumab
QL01FF05 atezolizumab
QL01FF06 cemiplimab
QL01FF07 dostarlimab
QL01FF08 prolgolimab
QL01FF09 tislelizumab
QL01FF10 retifanlimab
QL01FF11 sugemalimab
QL01FF12 serplulimab
QL01FF13 toripalimab
Last updated: 2024-01-17